LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Benamer, Hani (2006)
Publisher: Co-Action Publishing
Journal: Libyan Journal of Medicine
Languages: English
Types: Article
Subjects:

Classified by OpenAIRE into

mesheuropmc: mental disorders, body regions, nervous system diseases
Up to 15% of the adult population experiences restless legs syndrome, or Ekbom syndrome during their life [1]. The patients may present to a wide range of medical specialities such as general practitioners, general physicians, nephrologists, haematologists, obstetricians, endocrinologists, rheumatologists, and neurologists. Around 3% of patients experience major sleep disturbance that needs active medical treatment [2,3]. Therefore, knowing about Restless Legs Syndrome (RLS) is vital to provide a proper diagnosis and treatment to patients with this condition.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep1994; 17: 739-43.
    • 2. Hening W, Walters AS, Allen RP, Montplaisir JY, Myers A, Ferini-Strambi L.
    • Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004; 5: 237-46.
    • 3. Allen RP, Walters AS, Montplaisir JY, Hening W, Myers A, Bell TJ, FeriniStrambi L. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005; 165: 1286-92.
    • 4. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10: 634-42.
    • 5. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J.: Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Med. 2003; 4:101-19.
    • 6. Walters A, Le Brocq C, Dhar A, Hening W; the International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003; 4: 121-32.
    • 7. Diagnostic classification steering committee of the American sleep disorders association (M. Sateiaa, Chairperson). The international classification of sleep disorders: diagnostic and coding manual, second version. Chicago, Illinois: American Association of Sleep Medicine, 2005.
    • 8. Chaudhuri KR, Forbes A, Grosset DG, Lees A, Shneerson J, Schapira A, Stillman P, Williams A. Diagnosing restless legs syndrome (RLS) in primary care. Curr Med Res Opin 2004; 20: 1785-95.
    • 9. Chaudhuri KR. The restless leg syndrome. Time to recognise a very common movement disorder. Practical Neurol 2003; 3: 204-13.
    • 10. Polysomnography Task force: American sleep disorders association standards of practice committee. Practice parameters for the indications for polysomnography and related procedures. Sleep 1997;20:406-422.
    • 11. Stiasny-Kolster K, Metz A, Oertel W. Diagnosis and management of Restless Legs Syndrome. ACNR 2006; 5: 7-8.
    • 12. Trenkwalder C, Garcia-Borreguero D, Montagna P, Lainey E, de Weerd AW, Tidswell P, Saletu-Zyhlarz G, Telstad W, Ferini-Strambi L, on behalf the TREAT RLS 1(Therapy with Ropinirole; Efficacy and Tolerability in RLS 1) Study Group. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004; 75: 92.
    • 13. Hirvonen K, Partinen M, Alakuijala A, Jama L, Terttunen. Pramipexole induces a rapid and substantial improvement of idiopathic restless legs syndrome: Results of a large randomised, double blind, placebo-controlled, dosefinding study. Mov Disord 2004;Suppl 9: s421.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article

Collected from